Syphilis
Syphilis is a sexually and vertically transmissible Treponema pallidum infection with primary, secondary, latent and late multisystem manifestations; stage accurately, recognise neurological/ocular/pregnancy complications, treat through a specialist sexual-health pathway and document serological response.
In a nutshell
Syphilis is a staged, multisystem Treponema pallidum infection. Primary disease causes a chancre, secondary disease a disseminated mucocutaneous illness, latent disease is serological, and late disease can damage the cardiovascular, neurological and ocular systems. Stage it in specialist sexual-health care, treat with the appropriate penicillin regimen, notify partners, monitor RPR and protect pregnancy and organ function.
Classic presentation
A painless indurated chancre, or a widespread rash involving palms and soles with generalised lymphadenopathy; neurological, ocular, otological and pregnancy complications can occur at any stage.
Key points
- A chancre is classically painless and can be extragenital or atypical; spontaneous healing does not mean cure.
- Secondary syphilis is a multisystem disease: palms/soles rash, lymphadenopathy, mucous patches and condylomata lata are high-yield clues.
- Early latent syphilis is within 2 years; late latent syphilis is thereafter. Stage affects treatment duration and partner notification.
- Use treponemal tests to support diagnosis and a quantitative RPR to assess activity and monitor response; treponemal tests usually remain positive for life.
- Benzathine penicillin G 2.4 million units IM once treats early syphilis; late latent disease needs three weekly doses; neurosyphilis needs a CNS-penetrating regimen.
- Macrolides are no longer recommended because of resistance and treatment failures; pregnancy and confirmed allergy need specialist pathways.
- Neurosyphilis, ocular syphilis and otosyphilis can occur at any stage and require urgent organ-specific specialist input.
- The Jarisch–Herxheimer reaction is an expected treatment-related inflammatory reaction, not penicillin allergy.
- Follow RPR at 3, 6 and 12 months, then six-monthly if indicated; a fourfold rise suggests reinfection or treatment failure.
First-line investigation
Specialist sexual-health assessment with treponemal serology, a quantitative baseline RPR, lesion testing when available, HIV/other STI screening and targeted neurological, ocular, otological and pregnancy assessment.
Management
Identify organ and pregnancy emergencies
Stage and document baseline serology
Explain transmission and treatment reactions
Give stage- and site-appropriate therapy
Confirm response and detect reinfection
- Review clinically and repeat quantitative RPR at 3, 6 and 12 months, then six-monthly if indicated; a fourfold rise or inadequate fall requires assessment for reinfection, treatment failure and neurological disease.1
Exam traps
- A painful or multiple chancre does not exclude syphilis; the classic lesion is painless but clinical variation is common.
- A negative early serology does not exclude a recent chancre; repeat testing after 2 weeks and follow the specialist pathway.
- Do not use a positive treponemal test alone to diagnose active untreated disease or monitor cure; interpret it with prior treatment and quantitative RPR.
- Ocular or otological disease is not safely ruled out by a negative CSF result; urgent specialist management may be needed without relying on lumbar puncture.
- A Jarisch–Herxheimer reaction is not a beta-lactam allergy; do not stop treatment without senior assessment.
- Do not use macrolides as a routine alternative, and do not use doxycycline as a substitute for proven fetal penicillin therapy in pregnancy.
Illustrations
Key sources
- BASHH UK guideline for the management of syphilis 2024 (UK specialist guideline covering staging, serology, treatment, neurosyphilis, partner notification and follow-up; updated 25 September 2024.)Updated 25 Sept 2024
- NICE CKS: Syphilis (NICE Clinical Knowledge Summary for recognition, testing, referral and management; access may require NHS login.)
- BASHH UK guideline for the management of syphilis in pregnancy and children 2024 (UK specialist guideline covering maternal treatment, congenital syphilis, neonatal assessment, birth planning and paediatric follow-up.)Updated 25 Sept 2024
- UKHSA Syphilis Response Plan 2026–2029 (UKHSA national response plan covering surveillance, prevention, partner notification and coordinated sexual-health action.)Updated 1 Apr 2026
- BNF online (Current UK prescribing information for penicillins, doxycycline, ceftriaxone, corticosteroids and pregnancy prescribing; check current entries before prescribing.)
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

